VT News
Jed Cartwright

Jed Cartwright

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Pirates' Paul Skenes sets MLB record with dominant shutout performance
  • Air Force denies early retirement to transgender troops, forcing them to choose between a lump-sum payment or involuntary discharge without benefits.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Pirates' Paul Skenes sets MLB record with dominant shutout performance
  • Air Force denies early retirement to transgender troops, forcing them to choose between a lump-sum payment or involuntary discharge without benefits.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Jed Cartwright

Top Topics

Trending in U.S.

World

Sport